Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Aug-24 4:31 PM View:  | Crinetics Pharmaceuticals, ... (CRNX) | 26-Aug-24 | Private Sale (Planned) | 3,000 | $53.19 | $159,570.00 | (4%) 72.61K to 69.61K | |
| 14-Aug-24 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 12-Aug-24 | Private Sale (Planned) | 3,000 | $47.68 | $143,040.00 | (4%) 75.61K to 72.61K | |
| 26-Jul-24 4:38 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jul-24 | Private Sale (Planned) | 3,000 | $53.43 | $160,290.00 | (4%) 78.61K to 75.61K | |
| 12-Jul-24 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 10-Jul-24 | Private Sale (Planned) | 3,000 | $48.55 | $145,650.00 | (4%) 81.61K to 78.61K | |
| 26-Jun-24 4:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jun-24 | Private Sale (Planned) | 3,000 | $45.37 | $136,110.00 | (4%) 83.64K to 80.64K | |
| 11-Jun-24 4:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 10-Jun-24 | Private Sale (Planned) | 3,000 | $43.86 | $131,580.00 | (3%) 86.64K to 83.64K | |
| 30-May-24 4:28 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 28-May-24 | Private Sale (Planned) | 3,000 | $47.49 | $142,470.00 | (3%) 89.64K to 86.64K | |
| 14-May-24 6:29 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 10-May-24 | Private Sale (Planned) | 3,000 | $49.43 | $148,290.00 | (3%) 92.64K to 89.64K | |
| 20-Mar-24 6:33 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 3,655 | $38.14 | $139,402.00 | (4%) 96.3K to 92.64K | |
| 06-Mar-24 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 23,000 | -- | -- | 31% 73.3K to 96.3K | |
| 26-Jan-24 5:50 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jan-24 | Private Sale (Planned) | 3,000 | $37.26 | $111,780.00 | (4%) 76.3K to 73.3K | |
| 12-Jan-24 4:12 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 10-Jan-24 | Private Sale (Planned) | 3,000 | $37.65 | $112,950.00 | (4%) 79.3K to 76.3K | |
| 27-Dec-23 5:20 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 26-Dec-23 | Private Sale (Planned) | 3,000 | $35.89 | $107,670.00 | (4%) 82.3K to 79.3K | |
| 13-Dec-23 4:44 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 11-Dec-23 | Private Sale (Planned) | 3,000 | $32.87 | $98,610.00 | (4%) 85.3K to 82.3K | |
| 29-Nov-23 4:31 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 27-Nov-23 | Private Sale (Planned) | 3,000 | $31.84 | $95,520.00 | (3%) 88.3K to 85.3K | |
| 17-Mar-23 5:07 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Mar-23 | Payment of Exercise | 1,410 | $17.12 | $24,139.20 | (2%) 88.29K to 86.88K | |
| 03-Mar-23 4:38 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Mar-23 | Grant | 23,600 | -- | -- | 36% 64.69K to 88.29K | |
| 03-Feb-23 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Feb-23 | Sale (Planned) | 3,126 | $19.59 | $61,238.30 | (5%) 67.81K to 64.69K | |
| 27-Jan-23 4:26 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jan-23 | Sale (Planned) | 8,336 | $21.07 | $175,640.00 | (11%) 76.15K to 67.81K | |
| 19-Jan-23 4:28 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 17-Jan-23 | Sale (Planned) | 3,126 | $18.00 | $56,268.00 | (4%) 79.28K to 76.15K | |
| 05-Jan-23 4:23 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jan-23 | Sale (Planned) | 3,126 | $18.35 | $57,362.10 | (4%) 82.4K to 79.28K | |
| 19-Dec-22 5:11 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Dec-22 | Sale (Planned) | 3,126 | $16.00 | $50,016.00 | (4%) 85.53K to 82.4K | |
| 05-Dec-22 5:28 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Dec-22 | Sale (Planned) | 3,126 | $17.84 | $55,767.80 | (4%) 88.09K to 84.97K | |
| 17-Nov-22 4:46 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Nov-22 | Sale (Planned) | 3,126 | $18.72 | $58,518.70 | (3%) 91.22K to 88.09K | |
| 03-Nov-22 4:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Nov-22 | Sale (Planned) | 3,126 | $18.52 | $57,893.50 | (3%) 94.35K to 91.22K | |
| 19-Oct-22 5:34 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 17-Oct-22 | Sale (Planned) | 3,126 | $17.73 | $55,424.00 | (3%) 97.47K to 94.35K | |
| 05-Oct-22 4:40 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Oct-22 | Sale (Planned) | 3,126 | $19.64 | $61,394.60 | (3%) 100.6K to 97.47K | |
| 19-Sep-22 4:40 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Sep-22 | Sale (Planned) | 4,168 | $21.01 | $87,569.70 | (4%) 104.77K to 100.6K | |
| 09-Sep-22 4:20 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 07-Sep-22 | Sale (Planned) | 1,042 | $21.00 | $21,883.80 | (< 1%) 105.81K to 104.77K | |
| 06-Sep-22 4:20 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Sep-22 | Sale (Planned) | 3,126 | $18.59 | $58,112.30 | (3%) 108.93K to 105.81K | |
| 06-Sep-22 4:20 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-22 | Acquisition (other) | 1,336 | $11.02 | $14,722.70 | 1% 107.6K to 108.93K | |
| 04-May-22 5:01 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 02-May-22 | Sale (Planned) | 3,247 | $20.10 | $65,251.70 | (3%) 110.84K to 107.6K | |
| 21-Apr-22 5:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 18-Apr-22 | Market Sale (Planned) | 5,664 | $25.81 | $146,188.00 | (5%) 116.51K to 110.84K | 4% |
| 06-Apr-22 7:08 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 04-Apr-22 | Market Sale (Planned) | 9,000 | $23.97 | $215,762.00 | (7%) 125.51K to 116.51K | (4%) |
| 01-Apr-22 5:39 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Apr-22 | Sale (Planned) | 4,164 | $21.80 | $90,775.20 | (3%) 129.67K to 125.51K | |
| 01-Apr-22 5:39 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 31-Mar-22 | Sale (Planned) | 4,164 | $21.06 | $87,699.70 | (3%) 133.84K to 129.67K | |
| 17-Mar-22 4:33 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Mar-22 | Sale (Planned) | 3,123 | $18.94 | $59,149.60 | (2%) 136.96K to 133.84K | |
| 02-Mar-22 9:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Mar-22 | Sale (Planned) | 3,123 | $19.73 | $61,616.80 | (2%) 140.08K to 136.96K | |
| 02-Mar-22 9:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 28-Feb-22 | Grant | 16,500 | -- | -- | 13% 123.58K to 140.08K | |
| 17-Feb-22 4:34 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Feb-22 | Sale (Planned) | 3,123 | $18.64 | $58,212.70 | (2%) 126.71K to 123.58K | |
| 03-Feb-22 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Feb-22 | Sale (Planned) | 3,123 | $18.79 | $58,681.20 | (2%) 129.83K to 126.71K | |
| 20-Jan-22 4:47 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 18-Jan-22 | Market Sale (Planned) | 4,168 | $23.29 | $97,072.70 | (3%) 133.04K to 128.88K | (7%) |
| 06-Jan-22 4:37 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jan-22 | Market Sale (Planned) | 7,168 | $28.02 | $200,847.00 | (5%) 140.21K to 133.04K | 2% |
| 30-Dec-21 7:19 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 28-Dec-21 | Market Sale (Planned) | 3,000 | $27.95 | $83,851.80 | (2%) 143.21K to 140.21K | 3% |
| 17-Dec-21 4:28 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Dec-21 | Market Sale (Planned) | 5,668 | $24.14 | $136,826.00 | (4%) 148.88K to 143.21K | < 1% |
| 03-Dec-21 4:36 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Dec-21 | Market Sale (Planned) | 5,668 | $27.38 | $155,190.00 | (4%) 154.55K to 148.88K | 5% |
| 17-Nov-21 5:01 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Nov-21 | Market Sale (Planned) | 1,500 | $27.97 | $41,955.00 | (< 1%) 156.05K to 154.55K | 1% |
| 17-Nov-21 5:01 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Nov-21 | Market Sale (Planned) | 5,668 | $26.75 | $151,619.00 | (4%) 161.72K to 156.05K | (3%) |
| 09-Nov-21 5:44 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 08-Nov-21 | Market Sale (Planned) | 3,900 | $28.42 | $110,846.00 | (2%) 165.62K to 161.72K | 2% |
| 09-Nov-21 5:44 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 05-Nov-21 | Market Sale (Planned) | 12,600 | $27.95 | $352,195.00 | (7%) 178.22K to 165.62K | < 1% |